Search
PF-06291874
go.drugbank.com/drugs/DB15065InvestigationalPF-06291874 is under investigation in clinical trial NCT02175121 (Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of PF-06291874 as Oral Monotherapy To Treat Adults With Type 2 Diabetes
2'-Fucosyllactose
go.drugbank.com/drugs/DB16052Investigational2'-Fucosyllactose is under investigation in clinical trial NCT03847467 (Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-tnf Therapy).
PM02734
go.drugbank.com/drugs/DB05158InvestigationalPM02734 is a marine derived compound. PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types: breast, colon, pancreas, lung and prostate, among others.
MD-0727
go.drugbank.com/drugs/DB05948InvestigationalMD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.
Otenabant
go.drugbank.com/drugs/DB11745InvestigationalOtenabant has been investigated for the treatment of Obesity.
Epitizide
go.drugbank.com/drugs/DB13989ExperimentalEpitizide is an agent, commonly found in combination [triamterene], used to produce diuresis.
ABT-737
go.drugbank.com/drugs/DB17023ExperimentalAn inhibitor of members of the Bcl‑2 family of apoptosis regulators.[A252977]
APR-548
go.drugbank.com/drugs/DB17546InvestigationalAPR-548 is an analog of [eprenetapopt] and a reactivator of mutant p53.
INO-4995
go.drugbank.com/drugs/DB17834ExperimentalINO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.[A259781]